Dr. Nancy L. Allbritton's lab focuses on cutting-edge research in bioengineering to understand and combat cancer. They develop innovative microdevices and biomaterials to explore cellular behaviors in leukemia and colorectal cancer. By studying how lipid signaling and the tumor microenvironment affect cancer progression, the lab aims to improve treatment precision and patient outcomes.

Dr. Paul E. Kinahan's lab at the University of Washington focuses on improving cancer detection and treatment through advanced imaging technologies. They work on optimizing positron emission tomography (PET) imaging to better identify and characterize early-stage cancers, particularly in breast cancer therapy. The lab employs cutting-edge techniques, including machine learning and advanced imaging algorithms, to enhance diagnostic accuracy and potentially save lives by allowing earlier interventions.

Dr. Natalia Kleinhans's lab investigates how cannabis exposure during pregnancy affects infant brain development and behavior. By using advanced imaging techniques and neurobehavioral assessments, the lab aims to identify risks associated with prenatal cannabis use, especially given the increasing legalization and changing public perceptions of cannabis. Their research focuses on understanding neurodevelopmental changes in infants whose mothers used cannabis during pregnancy, aiming to inform public health policies and parental choices.

Dr. David J. Marcinek's lab at the University of Washington focuses on understanding how aging affects mitochondria, which are crucial for energy production in our cells. By studying changes in mitochondrial function and their impact on heart and muscle health, the lab aims to develop interventions that could improve quality of life for older adults. Current projects investigate the role of specific protein interactions in aging and the effects of natural supplements like urolithin A on cardiac function.

Dr. Joan E. Sanders' lab at the University of Washington focuses on improving the quality of life for people with transtibial amputations through advanced prosthetic technology. The main project aims to develop an automatically-adjusting prosthetic socket that adapts to changes in limb volume, relieving users of the burden of manual adjustments. By integrating smart algorithms and user-friendly interfaces, the research seeks to foster greater independence and better limb health for users.

Dr. Michael Regnier's lab at the University of Washington focuses on studying myosin, a key protein in muscle contraction, to understand how genetic mutations affect heart health. By using advanced computer simulations and experimental models, the lab examines the structural and functional impact of specific protein variants associated with heart diseases. Their work combines cutting-edge techniques like molecular dynamics and high-resolution imaging, aiming to enhance understanding of cardiac conditions at the cellular level.

Dr. Xiaohu Gao's lab at the University of Washington focuses on developing innovative methods for delivering RNA-based therapies, particularly in cancer treatment. By utilizing advanced nanotechnology, the lab is creating unique RNA nanocarriers that can effectively deliver small interfering RNA (siRNA) while overcoming challenges associated with traditional delivery methods. The research aims to enhance the efficiency and specificity of siRNA delivery for therapeutic applications.

Dr. Patrick S. Stayton's lab focuses on developing innovative therapies for respiratory infections, particularly those caused by coronaviruses and antibiotic-resistant bacteria. By utilizing advanced biomaterials and drug delivery systems, the lab aims to create inhalable treatments that can target lung infections effectively and improve outcomes for patients, especially in crises like pandemics. Their research seeks to revolutionize how we combat pulmonary pathogens through targeted drug delivery and combination therapies.

Dr. Chun Yuan's lab at the University of Washington focuses on advancing techniques in MRI to better understand and classify ischemic strokes. By developing automated analysis tools, their research aims to provide clearer diagnostics for stroke patients, particularly those with unclear causes, allowing for more targeted treatment options. The lab integrates state-of-the-art imaging and machine learning methods to enhance stroke prevention strategies.

Dr. Patrick M. Boyle's lab focuses on understanding the mechanisms behind strokes related to heart conditions, specifically those involving fibrosis in the left atrium. Using advanced computer simulations and medical imaging, the lab aims to uncover how changes in heart structure and function contribute to stroke risks. Their goal is to develop a personalized risk assessment tool that will help improve stroke prevention strategies for patients who have atrial fibrillation or other risk factors.

Dr. Albert Folch's lab focuses on advancing cancer treatment through innovative drug testing technologies. By integrating microfluidics with advanced biosensors, they aim to create platforms that simulate the tumor microenvironment, allowing for more accurate testing of cancer therapies. Their work strives to enhance personalized medicine and improve the success rate of drug therapies, especially immunotherapies.

Wendy E Thomas's lab at the University of Washington studies how certain bacteria, specifically oral streptococci, contribute to a serious heart infection called infective endocarditis. Her research focuses on how these bacteria interact with sugars on human cells, which influences their ability to cause infection. By understanding these interactions better, the lab aims to find new strategies for preventing and treating this life-threatening condition.

Dr. Robert S Miyaoka's lab at the University of Washington focuses on improving cancer treatment for neuroendocrine tumor patients through precision medicine. They are developing an innovative at-home device that allows patients to monitor their radiation exposure safely and conveniently, enabling personalized therapies based on individual measurements. The lab aims to make cancer treatments more effective while reducing side effects and the need for frequent hospital visits.

Dr. James D. Bryers' lab focuses on innovative vaccine delivery systems using injectable hydrogels. They aim to develop self-replicating mRNA vaccines specifically targeting Staphylococcus aureus, a dangerous bacteria responsible for severe infections. By creating biodegradable hydrogel depots, the lab seeks to improve vaccine efficacy and safety through a single injection method rather than repeated doses.

Dr. Cecilia Giachelli's lab at the University of Washington is focused on understanding how and why calcium builds up in blood vessels and heart valves, a process known as vascular calcification. This condition can lead to serious heart issues, especially in older adults and those with diabetes or kidney disease. The lab investigates the biological processes and genetic factors involved in this calcification to identify potential treatments and biomarkers that can improve cardiovascular health and prevent complications.